Correction to: The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion.

Park, Sophie; Kelaidi, Charikleia; Meunier, Mathieu; Casadevall, Nicole; Gerds, Aaron T; Platzbecker, Uwe

Park, Sophie; Kelaidi, Charikleia; Meunier, Mathieu; Casadevall, Nicole; Gerds, Aaron T; Platzbecker, Uwe.

Afiliação

Park S; CHU Grenoble, Université Grenoble Alpes, Institute for Advanced Biosciences, INSERM U1209, CNRS UMR 5309, CS 10217, 38043, Grenoble, France. spark@chu-grenoble.fr.
Kelaidi C; Aghia Sophia Children's Hospital, Athens, Greece.
Meunier M; CHU Grenoble, Université Grenoble Alpes, Institute for Advanced Biosciences, INSERM U1209, CNRS UMR 5309, CS 10217, 38043, Grenoble, France.
Casadevall N; Hôpital Saint-Antoine, Paris, France.
Gerds AT; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Platzbecker U; Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, Leipzig University Hospital, Leipzig, Germany.

Ann Hematol ; 99(1): 21, 2020 01.

Article em En | MEDLINE | ID: mdl-31788722

ABSTRACT

ABSTRACT

This article was originally published without an Open Access but due to the authors final decision to opt for Open Choice this correction was created.

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google